[The effect of miramistin on the phagocytic activity of the urethral neutrophilic granulocytes in patients with chronic urethroprostatitis].
It was found that addition of mirastimin to the traditional anti-inflammatory treatment results in stimulation of the absorptive capacity of the urethral phagocytes and improves the results of treatment of patients with chronic urethroprostatitis. The immunomodulator mirastimin should be given with consideration of the initial functional state of urethral neutrophilic granulocytes.
Vozianov
A F
AF
Krivoshein
Iu S
IuS
Pasechnikov
S P
SP
Kovalenko
V V
VV
Shatrov
V A
VA
Kuznetsova
L V
LV
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001548:Benzalkonium Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects* / Q000276:immunology; D011472:Prostatitis / Q000188:drug therapy* / Q000276:immunology; D014521:Urethra / Q000187:drug effects* / Q000276:immunology; D014526:Urethritis / Q000188:drug therapy* / Q000276:immunology
D000890:Anti-Infective Agents; D001548:Benzalkonium Compounds; C058048:miramistin
Vliianie miramistina na fagotsitarnuiu aktivnost' uretral'nykh neĭtrofil'nykh granulotsitov u bol'nykh khronicheskim uretroprostatitom.